BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 11179461)

  • 1. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
    Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular antioxidant effects of atorvastatin in vitro and in vivo.
    Wassmann S; Laufs U; Müller K; Konkol C; Ahlbory K; Bäumer AT; Linz W; Böhm M; Nickenig G
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):300-5. PubMed ID: 11834532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of HMG CoA reductase inhibition on small GTPases in the heart.
    Laufs U; Kilter H; Konkol C; Wassmann S; Böhm M; Nickenig G
    Cardiovasc Res; 2002 Mar; 53(4):911-20. PubMed ID: 11922901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
    Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells.
    Ichiki T; Takeda K; Tokunou T; Iino N; Egashira K; Shimokawa H; Hirano K; Kanaide H; Takeshita A
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1896-901. PubMed ID: 11742861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.
    Tanaka S; Fukumoto Y; Nochioka K; Minami T; Kudo S; Shiba N; Takai Y; Williams CL; Liao JK; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1591-600. PubMed ID: 23640485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression.
    Nickenig G; Strehlow K; Bäumer AT; Baudler S; Wassmann S; Sauer H; Böhm M
    Br J Pharmacol; 2000 Oct; 131(4):795-803. PubMed ID: 11030730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.
    Rashid M; Tawara S; Fukumoto Y; Seto M; Yano K; Shimokawa H
    Circ J; 2009 Feb; 73(2):361-70. PubMed ID: 19060417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells.
    Shyu KG; Chen SC; Wang BW; Cheng WP; Hung HF
    Clin Sci (Lond); 2012 Jan; 122(1):33-42. PubMed ID: 21806545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
    Kolyada AY; Fedtsov A; Madias NE
    Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.
    Guijarro C; Blanco-Colio LM; Ortego M; Alonso C; Ortiz A; Plaza JJ; Díaz C; Hernández G; Egido J
    Circ Res; 1998 Sep; 83(5):490-500. PubMed ID: 9734471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclic AMP-dependent kinase by expression of a protein kinase inhibitor/enhanced green fluorescent fusion protein attenuates angiotensin II-induced type 1 AT1 receptor mRNA down-regulation in vascular smooth muscle cells.
    Wang X; Murphy TJ
    Mol Pharmacol; 1998 Sep; 54(3):514-24. PubMed ID: 9730910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Rac-1 GTPase by Estrogen.
    Laufs U; Adam O; Strehlow K; Wassmann S; Konkol C; Laufs K; Schmidt W; Böhm M; Nickenig G
    J Biol Chem; 2003 Feb; 278(8):5956-62. PubMed ID: 12493759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress.
    Bruder-Nascimento T; Callera GE; Montezano AC; Belin de Chantemele EJ; Tostes RC; Touyz RM
    Life Sci; 2019 Mar; 221():29-34. PubMed ID: 30721707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Kiyono T; Fleck E; Van Herle A; Graf K; Law RE
    Eur J Pharmacol; 2003 Feb; 462(1-3):15-23. PubMed ID: 12591091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
    Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation.
    Dechend R; Gieffers J; Dietz R; Joerres A; Rupp J; Luft FC; Maass M
    Circulation; 2003 Jul; 108(3):261-5. PubMed ID: 12860900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide.
    Ichiki T; Usui M; Kato M; Funakoshi Y; Ito K; Egashira K; Takeshita A
    Hypertension; 1998 Jan; 31(1 Pt 2):342-8. PubMed ID: 9453326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin inhibits angiotensin II-induced T-type Ca2+ channel expression in endothelial cells.
    Wang D; Hirase T; Inoue T; Node K
    Biochem Biophys Res Commun; 2006 Aug; 347(2):394-400. PubMed ID: 16842760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.